Effect of 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid in combination with carboplatin on gastric carcinoma growth in vivo

Table 3 Effect of NM-3 on MVD (mean ± SD)

Groups	n	MVD
Normal saline	10	7.30 ± 0.53
NM-3 (10 mg/kg)	10	5.10 ± 0.40a
NM-3 (20 mg/kg)	10	4.72 ± 0.51a
NM-3 (40 mg/kg)	8	2.02 ± 0.50ac
NM-3 (10 mg/kg) + carplatin	10	4.96 ± 0.37a
NM-3 (20 mg/kg) + carplatin	10	4.80 ± 0.39a
NM-3 (40 mg/kg) + carplatin	8	1.78 ± 0.42ac
Carplatin	10	6.98 ± 0.45

^aP < 0.05 vs normal saline control group and carboplatin group,

^cP < 0.05 vs NM-3 (10 mg/kg) group.